Show simple item record

dc.contributor.authorRankin, Den
dc.contributor.authorKimbell, Ben
dc.contributor.authorHovorka, Romanen
dc.contributor.authorLawton, Jen
dc.date.accessioned2020-12-19T00:32:13Z
dc.date.available2020-12-19T00:32:13Z
dc.date.issued2021-01-20en
dc.identifier.issn1742-3953
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/315313
dc.description.abstractObjectives Type 1 diabetes can have life-shattering consequences for adolescents and parents. A closed-loop system is a cutting-edge technology which automatically regulates glucose to reduce the burden of diabetes management. We explored adolescents’ and parents’ experiences of using this technology to understand how it affects their biographies and everyday lives. Methods In-depth interviews with 18 adolescents newly diagnosed with type 1 diabetes and 21 parents after ≥12 months experience using closed-loop technology. Data were analysed thematically. Results Participants reported very few disruptions to their lives when using a closed-loop. Reports of family conflict were minimal as the closed-loop enabled dietary flexibility and glucose levels to be checked effortlessly. Adolescents described doing ‘normal’ activities without worrying about high/low glucose, and parents reported allowing them to do so unsupervised because the closed-loop would regulate their glucose and keep them safe. Some adolescents expressed concerns about the visibility of components and, to avoid stigma, described curtailing activities such as swimming. Participants described how the closed-loop enabled adolescents to be in control of, or create distance from, diabetes. Discussion The closed-loop has life-enhancing consequences for both adolescents and parents and helps to reduce the biographical disruption of type 1 diabetes in this age group.
dc.format.mediumPrint-Electronicen
dc.languageengen
dc.rightsAll rights reserved
dc.titleAdolescents' and their parents' experiences of using a closed-loop system to manage type 1 diabetes in everyday life: qualitative study.en
dc.typeArticle
prism.publicationDate2021en
prism.publicationNameChronic illnessen
prism.startingPage1742395320985924
dc.identifier.doi10.17863/CAM.62419
dcterms.dateAccepted2020-12-10en
rioxxterms.versionofrecord10.1177/1742395320985924en
rioxxterms.versionAM
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2021-01-20en
dc.contributor.orcidRankin, D [0000-0002-5835-3402]
dc.contributor.orcidHovorka, Roman [0000-0003-2901-461X]
dc.identifier.eissn1745-9206
rioxxterms.typeJournal Article/Reviewen
pubs.funder-project-idDepartment of Health (via National Institute for Health Research (NIHR)) (EME 14/23/09)
pubs.funder-project-idWellcome Trust (100574/B/12/Z)
pubs.funder-project-idHelmsley Charitable Trust (#2016PG-T1D046)
pubs.funder-project-idCambridge University Hospitals NHS Foundation Trust (CUH) (146281)
pubs.funder-project-idWellcome Trust (100574/Z/12/Z)
cam.orpheus.successMon Jan 25 12:05:57 GMT 2021 - Embargo updated*
cam.orpheus.counter3*
rioxxterms.freetoread.startdate2021-01-20


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record